인프라·DevOps 스킬

Use when configuring Laravel Reverb — the first-party WebSocket server with Pusher protocol compatibility, horizontal scaling, and Pulse monitoring.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Use when working with Docker — Dockerfile edits, docker-compose services, containers, or the dual-container (fast + Xdebug) setup — even when the user just says 'my container won't start'.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Use when working with AWS resources — ECS Fargate, ECR, EFS, Secrets Manager, gomplate templates, multi-env deployments — even when the user says 'deploy to staging' without naming AWS.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Use when filling knowledge-layer context files — auth-model, tenant-boundaries, data-sensitivity, deployment-order, observability — interactive template walkthrough.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Provides monitoring schedule for transgender males on testosterone therapy, detailing timing of clinical visits, laboratory tests, and assessment for virilization and adverse reactions. It is triggered when a clinician manages a transgender male patient on gender‑affirming hormone therapy and needs to schedule appropriate follow‑up.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

This skill checks for contraindications or sources of inaccuracy that may affect continuous glucose monitoring (CGM) reliability in hospitalized adults. It is triggered when clinicians ask, “Are there factors that could make CGM unreliable?” or when assessing for skin infection, hypoperfusion, hypovolemia, vasoactive/pressor therapy, or medications such as acetaminophen >4 g/day, dopamine, vitamin C, or hydroxyurea.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Recommends CGM over SMBG for type 1 diabetes patients on multiple daily injections to reduce hypoglycemia risk. Triggered by clinician questions such as "Should I use CGM or SMBG for this T1D patient on MDI?" or "Is CGM preferred for glucose monitoring in this patient?"

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

This skill suggests using real-time continuous glucose monitoring (CGM) and algorithm-driven insulin pumps (ADIPs) rather than multiple daily injections (MDIs) with self-monitoring of blood glucose (SMBG) three or more times daily for adults and children with type 1 diabetes (T1D). Trigger phrases include "Should I use RT-CGM+ADIP or MDI+SMBG for this T1D patient?" or "Is intensive pump therapy indicated for this patient?"

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

This skill indicates the need for periodic prolactin monitoring in transgender females undergoing estrogen therapy. Clinical triggers include a transgender female patient receiving estrogen treatment.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Provides schedule for monitoring during sex hormone induction. Trigger: patient initiating gender-affirming hormone therapy (GAHT).

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Provides a monitoring schedule for patients receiving GnRH agonist therapy for pubertal suppression. Trigger phrases include 'patient undergoing GnRH agonist therapy' or 'initiating pubertal suppression'.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

This skill suggests using real-time continuous glucose monitoring (CGM) rather than no CGM for outpatients with type 2 diabetes (T2D) who take insulin and/or sulfonylureas and are at high risk for hypoglycemia. It is triggered by clinician questions such as "Should I use CGM for this T2D patient on insulin or sulfonylureas with high hypoglycemia risk?" or "Is CGM indicated for this patient?"

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Provides monitoring schedule for transgender females on estrogen therapy, including clinical evaluation, hormone levels, prolactin, electrolytes, BMD, and cancer screening. Triggered when a transgender female is receiving estrogen therapy for gender affirmation.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Suggests CSII with good adherence to monitoring and dosing for adults with type 2 diabetes mellitus who have poor glycemic control despite intensive insulin therapy, oral agents, other injectable therapy, and lifestyle modifications. Trigger phrases include 'T2DM on multiple injectables still uncontrolled' and 'Consider pump for insulin-requiring T2DM failing other therapies'.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Suggests that clinicians continue CSII in hospitalized patients with type 1 or type 2 diabetes when the institution has clear protocols for evaluating pump candidates and appropriate monitoring and safety procedures. Trigger phrases include: 'Admitted patient on pump, check hospital pump policy' and 'Inpatient with diabetes using pump, verify institutional guidelines'.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Suggests either continuous glucose monitor (CGM) or self-monitoring of blood glucose (SMBG) for pregnant individuals with type 2 diabetes. Triggers include decisions about glucose monitoring methods for pregnant patients with T2DM needing a monitoring strategy.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Recommends using continuous glucose monitoring instead of fingerstick self-monitoring for type 1 diabetes patients on multiple daily injections to reduce hypoglycemia risk. Use when a clinician evaluates glucose monitoring options for T1D on MDIs or manages hypoglycemia-prone T1D patients.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Recommends real-time continuous glucose monitoring (RT-CGM) for adult patients with type 1 diabetes mellitus (T1DM) whose hemoglobin A1C is above individualized target. Consider when clinician notes 'T1DM A1C above goal, consider RT-CGM' or 'Patient willing to wear CGM daily, A1C elevated'.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Reassesses annually the patient’s use of self-monitoring blood glucose to calibrate the CGM system. Triggered by ‘Yearly calibration practice review’ or ‘Annual check of SMBG calibration adherence’.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Assesses whether a patient performs self-monitoring blood glucose (SMBG) fingerstick calibrations as required for their real-time CGM system. Triggers include: 'Verify patient performs fingerstick calibrations', 'Ensure calibration schedule is followed'.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Confirms patient understands that continuous glucose monitoring complements but does not replace self-monitoring of blood glucose. Triggers include: 'Clarify CGM role alongside fingersticks', 'Ensure patient knows CGM does not eliminate need for SMBG'.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

This skill guides clinicians to reassess glucose monitoring frequency when discontinuing continuous subcutaneous insulin infusion (CSII) or transitioning to multiple daily injections (MDI). It is triggered by phrases such as 'Plan for glucose monitoring after pump stop' or 'Determine SMBG/CGM frequency post-pump' to ensure individualized glycemic goals are met.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Suggests initiating inpatient continuous glucose monitoring (CGM) for select hospitalized patients at high risk for hypoglycemia, combined with periodic point-of-care glucose checks for accuracy. Triggers include planning glucose monitoring for inpatients with prior severe hypoglycemia, renal or hepatic dysfunction, or age 65 years or older.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

The skill suggests using real-time continuous glucose monitoring (CGM) combined with algorithm-driven insulin pumps (ADIPs) rather than multiple daily injections (MDIs) with self-monitoring of blood glucose (SMBG) three or more times daily for adults and children with type 1 diabetes (T1D) to lower hypoglycemia incidence. Clinical triggers include discussions about insulin pump therapy, CGM use, or reducing hypoglycemia in T1D patients on intensive insulin regimens.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.